Ningbo Menovo Pharmaceutical Co.Ltd(603538) : the joint-stock enterprise MEC medical antigen testing products have a production capacity of more than 50 million people / year and carry nearly 10 million covid-19 kits to aid Hong Kong

The official account of WeChat Ningbo Menovo Pharmaceutical Co.Ltd(603538) said that recently, there were many large wooden boxes and heavy transport vehicles at the entrance of the Ningbo Menovo Pharmaceutical Co.Ltd(603538) sharp fund joint venture company, Meck Medical Technology Co., Ltd., and the loading and transportation of these wooden boxes and vehicles were the COVID-19 testing kit ordered by MSAR government to Meck medical company, with a total of 9 million 924 thousand people in Hongkong. This batch of covid-19 test kits supported by Merck medical in Hong Kong have obtained a number of authorized certifications from many countries and regions, such as EU CE certificate, German bfarm authorization, Australian TGA certification and French white list certification, and have a good reputation and evaluation. In addition to Hong Kong, China, the sales scope of covid-19 antigen detection products developed by Merck medicine has covered more than 40 countries and regions such as Germany, France, Austria, South America, Saudi Arabia, UAE and Argentina. The total export volume is tens of millions of people, and the production capacity is more than 50 million people / year. The main products of covid-19 business of Merck medicine are covid-19 antigen detection, covid-19 antigen self-test, covid-19 antibody detection, etc.